Aron Jaffe (@jaffeab) 's Twitter Profile
Aron Jaffe

@jaffeab

SVP @ curie.bio;Former SVP Head of Research @chromamedicine;EIR @ThirdRockV;Reg Med, uBiome group leader/Resp DA co-lead @NovartisScience. Opinions mine

ID: 387412842

linkhttps://bsky.app/profile/jaffeab.bsky.social calendar_today09-10-2011 01:06:12

1,1K Tweet

719 Followers

242 Following

Robert Nelsen (@rtnarch) 's Twitter Profile Photo

Measles is a cool disease to get to get “natural immunity” plus you will have less children to take of when they die.

Aron Jaffe (@jaffeab) 's Twitter Profile Photo

Opinion: Science funding cuts are based on flawed logic. Here’s the truth. – San Diego Union-Tribune sandiegouniontribune.com/2025/02/25/opi…

Aron Jaffe (@jaffeab) 's Twitter Profile Photo

Congratulations to Stefan Irion Seth Ettenberg & the entire BlueRock Therapeutics team! BlueRock Therapeutics receives FDA Fast Track Designation for OpCT-001 for the treatment of primary photoreceptor diseases  bluerocktx.com/bluerock-thera…

Veera Rajagopal  (@doctorveera) 's Twitter Profile Photo

I and my colleague, Sahar Gelfman, at RGC had the privilege to write a News and Views article for @nature about a recent work on Huntington's disease by Steve McCarroll and team. In this incredible work, through an innovative single cell RNA sequencing methodology, Handsaker et

I and my colleague, Sahar Gelfman, at RGC had the privilege to write a News and Views article for @nature about a recent work on Huntington's disease by <a href="/s_mccarroll/">Steve McCarroll</a> and team. 

In this incredible work, through an innovative single cell RNA sequencing methodology, Handsaker et
Aron Jaffe (@jaffeab) 's Twitter Profile Photo

FDA delays are bad in general, but for a small biotech they can be existential. Let’s hope this is an edge case. endpts.com/fda-delays-sma…

STAT (@statnews) 's Twitter Profile Photo

The custom-built gene editing treatment for 6-month-old KJ Muldoon could not have come at a more welcome or jarring time for CRISPR-powered biomedicine. trib.al/wgbNRSI

Aron Jaffe (@jaffeab) 's Twitter Profile Photo

When a therapeutic approach works, it's on us as a global community to figure out how to get it to ALL patients in need. Great piece by Jason Mast What Baby KJ means for the CRISPR gene editing industry statnews.com/2025/05/26/wha… via STAT

carolyn johnson (@carolynyjohnson) 's Twitter Profile Photo

In case you needed a smile this Tuesday: 10-month-old baby KJ, who received a bespoke gene-editing therapy after a six month scientific sprint - "graduated" from the hospital today and went HOME! YAY SCIENCE! Here's his story: wapo.st/451ZQjT

In case you needed a smile this Tuesday: 10-month-old baby KJ, who received a bespoke gene-editing therapy after a six month scientific sprint - "graduated" from the hospital today and went HOME!   YAY SCIENCE!   Here's his story: wapo.st/451ZQjT